Evidence map›Paper›PMID 24879016›Full record

ArticlePloS one2014

HIF1α and HIF2α exert distinct nutrient preferences in renal cells.

Alexandra Arreola, C Lance Cowey, Jonathan L Coloff, Jeffrey C Rathmell, W Kimryn Rathmell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Alexandra ArreolaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Genetics Department, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
C Lance CoweyDepartment of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Now at Baylor Sammons Cancer Center, Dallas, Texas, United States of America.
Jonathan L ColoffDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America; Now at Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States of America.
Jeffrey C RathmellDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
W Kimryn RathmellLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Genetics Department, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
University of North Carolina at Chapel Hill · USDuke Medical Center · USDuke University Hospital · USTexas Oncology · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Genetic Events in the Development of Renal Cell CarcinomaR01CA121781 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RATHMELL, WENDY KIMRYN · 2007 to 2011
$1.4M
Enhancing Translational Science via Prospective InvestigationK24CA172355 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RATHMELL, WENDY KIMRYN · 2013 to 2017
$870k
Identifying a Hypoxia Inducible Factor target profile in Renal Cell Carcinoma tumF31CA154080 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ARREOLA, ALEXANDRA · 2010 to 2014
$126k
NCI NIH HHS F31 CA154080NCI NIH HHS F31CA154080NCI NIH HHS K24 CA172355NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA121781NCI NIH HHS R01-CA121781
6 · The paper itself

Abstract

backgroundHypoxia Inducible Factors (HIF1α and HIF2α) are commonly stabilized and play key roles related to cell growth and metabolic programming in clear cell renal cell carcinoma. The relationship of these factors to discretely alter cell metabolic activities has largely been described in cancer cells, or in hypoxic conditions, where other confounding factors undoubtedly compete. These transcription factors and their specific roles in promoting cancer metabolic phenotypes from the earliest stages are poorly understood in pre-malignant cells.

methodsWe undertook an analysis of SV40-transformed primary kidney epithelial cells derived from newborn mice genetically engineered to express a stabilized HIF1α or HIF2α transgene. We examined the metabolic profile in relation to each gene.

resultsAlthough the cells proliferated similarly, the metabolic profile of each genotype of cell was markedly different and correlated with altered gene expression of factors influencing components of metabolic signaling. HIF1α promoted high levels of glycolysis as well as increased oxidative phosphorylation in complete media, but oxidative phosphorylation was suppressed when supplied with single carbon source media. HIF2α, in contrast, supported oxidative phosphorylation in complete media or single glucose carbon source, but these cells were not responsive to glutamine nutrient sources. This finding correlates to HIF2α-specific induction of Glul, effectively reducing glutamine utilization by limiting the glutamate pool, and knockdown of Glul allows these cells to perform oxidative phosphorylation in glutamine media.

conclusionHIF1α and HIF2α support highly divergent patterns of kidney epithelial cell metabolic phenotype. Expression of these factors ultimately alters the nutrient resource utilization and energy generation strategy in the setting of complete or limiting nutrients.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCarbonCell LineCulture MediaEndothelial PAS Domain-Containing Protein 1Epithelial CellsFoodGene ExpressionGlucoseGlutamic AcidHypoxia-Inducible Factor 1, alpha SubunitKidneyMetabolomeMiceOxidative PhosphorylationBasic Helix-Loop-Helix ProteinsCarbonCulture MediaEndothelial PAS Domain-Containing Protein 1GlucoseGlutamic AcidHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitTranscription Factors

Identifiers

PMID24879016
PMCPMC4039535
OpenAlexW2159183821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.